Legal & General Group Plc - CYTOMX THERAPEUTICS INC ownership

CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 120 filers reported holding CYTOMX THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of CYTOMX THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$23,000
-34.3%
8,372
+3.9%
0.00%
Q4 2021$35,000
-64.6%
8,056
-58.7%
0.00%
Q3 2021$99,000
+65.0%
19,528
+103.7%
0.00%
Q2 2021$60,000
-11.8%
9,586
+10.0%
0.00%
Q1 2021$68,000
+54.5%
8,716
+29.8%
0.00%
Q4 2020$44,0000.0%6,7150.0%0.00%
Q3 2020$44,000
-38.9%
6,715
-22.5%
0.00%
Q2 2020$72,000
+14.3%
8,662
+4.7%
0.00%
Q1 2020$63,000
-30.0%
8,273
-23.6%
0.00%
Q4 2019$90,000
+34.3%
10,822
+18.9%
0.00%
Q3 2019$67,000
-34.3%
9,0990.0%0.00%
Q2 2019$102,000
+14.6%
9,099
+9.1%
0.00%
Q1 2019$89,000
-29.4%
8,3420.0%0.00%
Q4 2018$126,000
-3.1%
8,342
+18.6%
0.00%
Q3 2018$130,000
-6.5%
7,036
+15.3%
0.00%
Q2 2018$139,000
-4.8%
6,102
+19.2%
0.00%
Q1 2018$146,000
-5.8%
5,118
-29.4%
0.00%
Q4 2017$155,000
+18.3%
7,2460.0%0.00%
Q3 2017$131,000
+29.7%
7,246
+12.4%
0.00%
Q2 2017$101,000
+17.4%
6,448
+28.6%
0.00%
Q1 2017$86,000
+48.3%
5,014
-4.7%
0.00%
Q4 2016$58,0000.0%5,261
+43.9%
0.00%
Q3 2016$58,000
+61.1%
3,6550.0%0.00%
Q2 2016$36,0003,6550.00%
Other shareholders
CYTOMX THERAPEUTICS INC shareholders Q4 2017
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 6,450,000$8,320,5001.17%
BVF INC/IL 6,595,801$8,508,5830.23%
Bronte Capital Management Pty Ltd. 925,245$1,193,5660.12%
Formidable Asset Management, LLC 318,111$410,3630.09%
Congress Park Capital LLC 112,450$145,0610.08%
Forefront Analytics, LLC 49,421$63,7540.04%
Ground Swell Capital, LLC 10,966$14,1460.02%
Clearline Capital LP 196,583$253,5920.02%
CORNERCAP INVESTMENT COUNSEL INC 81,352$104,9440.02%
ACADIAN ASSET MANAGEMENT LLC 2,646,190$3,4120.01%
View complete list of CYTOMX THERAPEUTICS INC shareholders